Design, synthesis, characterization, in silico studies, and in vitro anticancer evaluation of novel 7-methoxyquinolone-substituted triazole hybrids
Yazarlar (6)
Lemıye Allıto
Kafkas Üniversitesi, Türkiye
Dr. Öğr. Üyesi Ferah Cömert Önder Çanakkale Onsekiz Mart Üniversitesi, Türkiye
Prof. Dr. Ramazan Demirel Kafkas Üniversitesi, Türkiye
Alper Önder
Çanakkale Onsekiz Mart Üniversitesi, Türkiye
Prof. Dr. Özkan ÖZDEN Kafkas Üniversitesi, Türkiye
Doç. Dr. Musa ERDOĞAN Kafkas Üniversitesi, Türkiye
Devamını Göster...
Makale Türü Açık Erişim Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
Dergi Adı Future Medicinal Chemistry (Q3)
Dergi ISSN 1756-8919 Dergi Bilgileri (2025)
Dergi Tarandığı Indeksler SCI-Expanded
Makale Dili Türkçe Basım Tarihi 07-2025
Kabul Tarihi 01-07-2025 Yayınlanma Tarihi 03-07-2025
Cilt / Sayı / Sayfa 17 / 13 / 1559–1573 DOI 10.1080/17568919.2025.2533003
Makale Linki https://doi.org/10.1080/17568919.2025.2533003
UAK Araştırma Alanları
Biyokimya
Özet
Aims: The quinolone scaffold is a crucial member of the heterocyclic compound family in modern medicinal chemistry, exhibiting a broad range of biological activities. Since 4-quinolones are known to interact with significant drug targets, and due to the remarkable pharmacological properties of 1,2,3-triazole compounds, a molecular hybridization approach was used to design novel 7-methoxyquinolone-substituted triazole hybrid conjugates (QN1-QN11). Materials and methods: These hybrid compounds were evaluated to determine their anticancer activities in various breast and colon cancer cell lines, including BT20, MDA-MB-231, MCF7, and HT29. In addition, the apoptotic-like morphological changes in aggressive MDA-MB-231 cells were observed following treatment with the compounds for 48 hours. In silico studies, including molecular docking, molecular dynamics (MD) simulation, and MM/GBSA calculations, were carried out for the synthesized compounds against important cancer drug targets. Results: The highly cytotoxic agents QN10 and QN7 were identified with IC50 values of 4.49 ± 0.68 µM and 19.05 ± 1.58 µM in BT20 and HT29 cell lines, respectively. In addition, the morphologically changes were observed on MDA-MB-231 cells. Conclusions: These findings show that the synthesized click products are highly cytotoxic agents in cancer cell lines and may be considered as potential candidates for enzyme inhibition.
Anahtar Kelimeler
anticancer | click chemistry | MD simulation | molecular docking | Quinolone
BM Sürdürülebilir Kalkınma Amaçları
Atıf Sayıları
Scopus 6
Google Scholar 6
PubMed 4
Design, synthesis, characterization, in silico studies, and in vitro anticancer evaluation of novel 7-methoxyquinolone-substituted triazole hybrids